In recent years, there has been an increase in the number of aggressive androgen receptor variant prostate cancers with neuroendocrine characteristics (NEPC) or small cell characteristics (small cell prostate cancer) with low expression or deletion. The gene discussed is AR; the disease is prostate carcinoma.